American Society of Addiction Medicine (ASAM). "Opioid Addiction Disease 2015 Facts and Figures." Available at http://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf .
The guidelines provide recommendations on the use of MAT across treatment phases with an emphasis on the maintenance phase. Most of the guidelines were developed based upon expert opinion and scientific literature. Some guidelines focus on special populations and over half mention psychosocial treatment. The strength of the recommendation varies f
Stages of Treatment . Both opioid and alcohol use MAT guidelines tend to focus on stages of treatment -- assessment, withdrawal management (also referred to as detoxification), and maintenance -- whereby the recommended dosage of medication and frequency and intensity of MAT vary with the stage of treatment and the client's needs.
Even though the roadmap focuses on MAT for opioid use, we recognize that clinical guidelines and measures related to MAT for alcohol and other SUDs could be useful to guide the approach to developing and implementing MAT measures for opioid use. As such, we searched for and reviewed clinical guidelines that include MAT for opioid and alcohol use p
Opioid overdoses claim 17,000 American lives annually (ASAM 2015). Deaths by opioid overdose have nearly quadrupled from 1999 to 2013 (CDC 2015). Nearly 2.5 million Americans are currently at risk for overdoses -- 1.9 million are opioid-dependent, and 517,000 are addicted to heroin (ASAM 2015). In response to the growing opioid epidemic, the U.S.
LIST OF TABLES
TABLE B.1 : SAMHSA and NIAAA: Brief Guide to Medication for the Treatment of Alcohol Use Disorder
TABLE B.2 : NICE: Technology Appraisal Guidance of Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence
TABLE B.3 : WHO: Guidelines for the Identification and Management of Substance Use and SUD in Preg
LIST OF TABLES
TABLE A.1 : Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process
TABLE A.2 : Institute of Obstetricians and Gynecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Care Health Service Executive: Methadone Prescribing and Admini
Summary : In response to the growing opioid epidemic, the U.S. Department of Health and Human Services (HHS) announced a three-pronged initiative in March 2015 to: (1) improve opioid prescribing practices; (2) increase access to naloxone for overdose management; and (3) expand medication-assisted treatment (MAT) to reduce opioid dependence.
Mathematica Policy Research prepared this review under contract to the Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services (HHS) (HHSP23320100019WI/HHSP23337001T). Additional funding was provided by the HHS Substance Abuse and Mental Health Services Administration (SAMHSA). The authors
In response to the growing opioid epidemic, HHS announced a three-pronged initiative in March 2015 to: (1) improve opioid prescribing practices; (2) increase access to naloxone for overdose management; and (3) expand medication-assisted treatment (MAT) to reduce opioid dependence. In support of the initiative, ASPE contracted with Mathematica Poli
Type of Activity: Services
Funding Mechanism: Grant
Total Available Funding: $ 61.6 million
Number of Awards: 140 grants
Award Amount: Grants that provide outreach and pretreatment services are funded for an amount to pass $400,000/year/grant. Grants that provide clinical substance abuse treatment are funded up to $450,
Funding Mechanism: Grant
Total Available Funding: $9.6 million (FY 2009-2012 cohort)
$7.98 million (FY 2010-2013 cohort)
Number of Awards: 42 total
24 (FY 2009-2012)
18 (FY 2010-2013)
Length of Project Period: 3 years
Federal Partners: None